Buscar
Mostrando ítems 51-60 de 94
An Efficient Protocol For The Generation Of Monocyte Derived Dendritic Cells Using Serum-free Media For Clinical Applications In Post Remission Aml Patients
(Association of Clinical Scientists, 2014)
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome
(AMER SOC CLINICAL ONCOLOGY, 2010)
Purpose Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) primarily afflict older individuals. Hematopoietic cell transplantation (HCT) is generally not offered because of concerns of excess morbidity and ...
Actividades económicas, laborales, ambientales y aditivas con exposición a benceno y el desarrollo de leucemia mieloide aguda
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2022-03-31)
Paternal isodisomy 7q secondary to monosomy 7 at recurrence in a Down syndrome child with acute myelogenous leukemia
(2012)
Several human genetic variants have been associated with susceptibility or resistance to leprosy. The aim of this study was to assess whether gene polymorphisms of -308 G/A TNF-? and -819 T/C IL-10 are associated with ...
Cytotoxic Activity of Extracts from Plants of Central Argentina on Sensitive and Multidrug-Resistant Leukemia Cells: Isolation of an Active Principle from Gaillardia megapotamica
(Oxford University Press, 2018-05)
Plants are a significant reservoir of cytotoxic agents, including compounds with the ability to interfere with multidrug resistant (MDR) cells. With the aim of finding promising candidates for chemotherapy, 91 native and ...
SEMA3A partially reverses VEGF effects through binding to neuropilin-1
(Elsevier Science Bv, 2017)
Cross-talk between hematopoietic stem cells (HSCs) and bone marrow stromal cells (BMSCs) is essential for HSCs regulation and leukemogenesis. Studying bone marrow of myelodysplasia patients, a pre-leukemic condition, we ...
Toxicidad en sistema nervioso central y periférico del tratamiento quimioterapéutico en pacientes mayores de 18 años: revisión sistemática
(Bogotá - Medicina - Especialidad en Neurología ClínicaUniversidad Nacional de Colombia - Sede Bogotá, 2021-01)
Introduction: The development of cancer therapies offers a longer survival to the patients, but also exposes them to toxic effects that generate morbidity and even mortality. Chemotherapeutic agents have the potential to ...